Meloxicam, igurishwa ku izina rya Mobic n'indi, ni umuti urwanya ububyimbirwe utari steroide (NSAID) ukoreshwa mu kuvura ububabare n'ububyimbirwe mu ndwara za rubagimpande na osteoarthritis. Ikoreshwa mu kanwa cyangwa mu guterwa mu mitsi. Birasabwa ko ikoreshwa mu gihe gito gishoboka kandi ku gipimo gito.
Ingaruka mbi zikunze kugaragara zirimo kubabara mu nda, kuzungera, kubyimba, kuribwa umutwe, no kugira ibisebe. Ingaruka mbi zishobora kuba zirimo indwara z'umutima, gucika imitsi, ibibazo by'impyiko, n'ibisebe byo mu gifu. Ntibyemewe kuyikoresha mu gihembwe cya gatatu cy'uburumbuke. Ibuza cyclooxygenase-2 (COX-2) kurusha uko ibuza cyclooxygenase-1 (COX-1). Iri mu muryango w’ibinyabutabire bya oxicam kandi ifitanye isano rya hafi na piroxicam.
Meloxicam yahawe uburenganzira bwo gukoresha imiti mu 1977, yemererwa gukoreshwa mu buvuzi muri Leta Zunze Ubumwe za Amerika mu 2000. Yakozwe na Boehringer Ingelheim, ariko iraboneka nk'umuti usanzwe. Muri Leta Zunze Ubumwe za Amerika ikiguzi cya buri dose kiri munsi ya 0.02$ ya Amerika as of 2018. Mu Bwongereza igura ibiro bigera kuri 0.13 as of 2018. Mu 2017, wari umuti wa 38 ukunze kwakirwa cyane muri Leta Zunze Ubumwe za Amerika, aho urenga 19 imiti ikoreshwa mu kuvura indwara ya kanseri ingana na miliyoni imwe.
